MiMedx Group Inc (MDXG)
6.245
-0.18
(-2.88%)
USD |
NASDAQ |
Apr 25, 16:00
6.245
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Free Cash Flow: 24.62M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 24.62M |
| September 30, 2023 | 7.511M |
| June 30, 2023 | -4.046M |
| March 31, 2023 | -14.91M |
| December 31, 2022 | -20.58M |
| September 30, 2022 | -16.79M |
| June 30, 2022 | -11.66M |
| March 31, 2022 | -7.074M |
| December 31, 2021 | -5.452M |
| September 30, 2021 | -14.45M |
| June 30, 2021 | -25.49M |
| March 31, 2021 | -30.22M |
| December 31, 2020 | -34.82M |
| September 30, 2020 | -46.19M |
| June 30, 2020 | -44.30M |
| March 31, 2020 | -38.92M |
| December 31, 2019 | -41.63M |
| September 30, 2019 | -18.14M |
| June 30, 2019 | -13.80M |
| March 31, 2019 | 2.617M |
| December 31, 2018 | 25.77M |
| September 30, 2018 | 45.81M |
| June 30, 2018 | 61.45M |
| March 31, 2018 | 54.94M |
| December 31, 2017 | 57.54M |
| Date | Value |
|---|---|
| September 30, 2017 | 51.40M |
| June 30, 2017 | 35.96M |
| March 31, 2017 | 29.60M |
| December 31, 2016 | 16.80M |
| September 30, 2016 | 5.78M |
| June 30, 2016 | 10.12M |
| March 31, 2016 | 6.335M |
| December 31, 2015 | 12.13M |
| September 30, 2015 | 17.12M |
| June 30, 2015 | 19.74M |
| March 31, 2015 | 18.56M |
| December 31, 2014 | 13.65M |
| September 30, 2014 | 6.559M |
| June 30, 2014 | -0.9268M |
| March 31, 2014 | -3.384M |
| December 31, 2013 | -3.31M |
| September 30, 2013 | -4.766M |
| June 30, 2013 | -6.381M |
| March 31, 2013 | -4.806M |
| December 31, 2012 | -3.969M |
| September 30, 2012 | -4.587M |
| June 30, 2012 | -4.925M |
| March 31, 2012 | -6.584M |
| December 31, 2011 | -7.151M |
| September 30, 2011 | -7.416M |
Free Cash Flow Range, Past 5 Years
-46.19M
Minimum
Sep 2020
24.62M
Maximum
Dec 2023
-18.75M
Average
-16.79M
Median
Sep 2022
Free Cash Flow Benchmarks
| TELA Bio Inc | -41.47M |
| Amylyx Pharmaceuticals Inc | 10.68M |
| CEL-SCI Corp | -23.45M |
| AIM ImmunoTech Inc | -21.85M |
| IGC Pharma Inc | -6.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 10.26M |
| Cash from Investing (Quarterly) | -0.481M |
| Cash from Financing (Quarterly) | -8.94M |
| Free Cash Flow Per Share (Quarterly) | 0.0669 |
| Free Cash Flow to Equity (Quarterly) | 10.64M |
| Free Cash Flow to Firm (Quarterly) | 13.72M |
| Free Cash Flow Yield | 3.18% |